FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
Replimunes
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
